Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 90

1.

A multilocus sequence typing scheme for Mycobacterium abscessus complex (MAB-multilocus sequence typing) using whole-genome sequencing data.

Wuzinski M, Bak AK, Petkau A, B Demczuk WH, Soualhine H, Sharma MK.

Int J Mycobacteriol. 2019 Jul-Sep;8(3):273-280. doi: 10.4103/ijmy.ijmy_106_19.

2.

Shared genome analyses of notable listeriosis outbreaks, highlighting the critical importance of epidemiological evidence, input datasets and interpretation criteria.

Reimer A, Weedmark K, Petkau A, Peterson CL, Walker M, Knox N, Kent H, Mabon P, Berry C, Tyler S, Tschetter L, Jerome M, Allen V, Hoang L, Bekal S, Clark C, Nadon C, Van Domselaar G, Pagotto F, Graham M, Farber J, Gilmour M.

Microb Genom. 2019 Jan;5(1). doi: 10.1099/mgen.0.000237. Epub 2019 Jan 16.

3.

SNVPhyl: a single nucleotide variant phylogenomics pipeline for microbial genomic epidemiology.

Petkau A, Mabon P, Sieffert C, Knox NC, Cabral J, Iskander M, Iskander M, Weedmark K, Zaheer R, Katz LS, Nadon C, Reimer A, Taboada E, Beiko RG, Hsiao W, Brinkman F, Graham M, Van Domselaar G.

Microb Genom. 2017 Jun 8;3(6):e000116. doi: 10.1099/mgen.0.000116. eCollection 2017 Jun 30.

4.

A Primer on Infectious Disease Bacterial Genomics.

Lynch T, Petkau A, Knox N, Graham M, Van Domselaar G.

Clin Microbiol Rev. 2016 Oct;29(4):881-913. doi: 10.1128/CMR.00001-16. Epub 2016 Sep 7. Review.

5.

A Comparative Analysis of the Lyve-SET Phylogenomics Pipeline for Genomic Epidemiology of Foodborne Pathogens.

Katz LS, Griswold T, Williams-Newkirk AJ, Wagner D, Petkau A, Sieffert C, Van Domselaar G, Deng X, Carleton HA.

Front Microbiol. 2017 Mar 13;8:375. doi: 10.3389/fmicb.2017.00375. eCollection 2017.

6.

Genomic insights from whole genome sequencing of four clonal outbreak Campylobacter jejuni assessed within the global C. jejuni population.

Clark CG, Berry C, Walker M, Petkau A, Barker DO, Guan C, Reimer A, Taboada EN.

BMC Genomics. 2016 Dec 3;17(1):990.

7.

Sequence database versioning for command line and Galaxy bioinformatics servers.

Dooley DM, Petkau AJ, Van Domselaar G, Hsiao WW.

Bioinformatics. 2016 Apr 15;32(8):1275-7. doi: 10.1093/bioinformatics/btv724. Epub 2015 Dec 12.

8.

Personalized activity index, a new safety monitoring tool for multiple sclerosis clinical trials.

Zhao Y, Kondo Y, Traboulsee A, Li DK, Riddehough A, Petkau AJ.

Mult Scler J Exp Transl Clin. 2015 Apr 24;1:2055217315577829. doi: 10.1177/2055217315577829. eCollection 2015 Jan-Dec.

9.

Further investigation of safety monitoring guidelines based on magnetic resonance imaging lesion activity in multiple sclerosis clinical trials.

Dong J, Zhao Y, Petkau AJ, Li DK, Riddehough A, Traboulsee A.

Mult Scler. 2015 Jan;21(1):101-4. doi: 10.1177/1352458514533846. Epub 2014 May 22.

PMID:
24852923
10.

Evolutionary dynamics of Vibrio cholerae O1 following a single-source introduction to Haiti.

Katz LS, Petkau A, Beaulaurier J, Tyler S, Antonova ES, Turnsek MA, Guo Y, Wang S, Paxinos EE, Orata F, Gladney LM, Stroika S, Folster JP, Rowe L, Freeman MM, Knox N, Frace M, Boncy J, Graham M, Hammer BK, Boucher Y, Bashir A, Hanage WP, Van Domselaar G, Tarr CL.

mBio. 2013 Jul 2;4(4). pii: e00398-13. doi: 10.1128/mBio.00398-13.

11.

MRI-based clinical trials in relapsing-remitting MS: new sample size calculations based on a longitudinal model.

Altman RM, Petkau AJ, Vrecko D, Smith A.

Mult Scler. 2012 Nov;18(11):1600-8. doi: 10.1177/1352458512444326. Epub 2012 Apr 11.

PMID:
22495948
12.

Comparative genomics of Vibrio cholerae from Haiti, Asia, and Africa.

Reimer AR, Van Domselaar G, Stroika S, Walker M, Kent H, Tarr C, Talkington D, Rowe L, Olsen-Rasmussen M, Frace M, Sammons S, Dahourou GA, Boncy J, Smith AM, Mabon P, Petkau A, Graham M, Gilmour MW, Gerner-Smidt P; V. cholerae Outbreak Genomics Task Force.

Emerg Infect Dis. 2011 Nov;17(11):2113-21. doi: 10.3201/eid1711.110794.

13.

Evaluation of safety monitoring guidelines based on MRI lesion activity in multiple sclerosis.

Riddell CA, Zhao Y, Li DK, Petkau AJ, Riddehough A, Cutter GR, Traboulsee A.

Neurology. 2011 Dec 13;77(24):2089-96. doi: 10.1212/WNL.0b013e31823d762d. Epub 2011 Nov 16.

PMID:
22094474
14.

A longitudinal model for magnetic resonance imaging lesion count data in multiple sclerosis patients.

MacKay Altman R, Petkau AJ, Vrecko D, Smith A.

Stat Med. 2012 Feb 28;31(5):449-69. doi: 10.1002/sim.4394. Epub 2011 Oct 3.

PMID:
21964585
15.

Predictors of sexual desire disorders in women.

Brotto LA, Petkau AJ, Labrie F, Basson R.

J Sex Med. 2011 Mar;8(3):742-53. doi: 10.1111/j.1743-6109.2010.02146.x. Epub 2010 Dec 8.

PMID:
21143419
16.

Interactive microbial genome visualization with GView.

Petkau A, Stuart-Edwards M, Stothard P, Van Domselaar G.

Bioinformatics. 2010 Dec 15;26(24):3125-6. doi: 10.1093/bioinformatics/btq588. Epub 2010 Oct 17.

17.

Role of androgens in women's sexual dysfunction.

Basson R, Brotto LA, Petkau AJ, Labrie F.

Menopause. 2010 Sep-Oct;17(5):962-71. doi: 10.1097/gme.0b013e3181d59765.

PMID:
20539247
18.

Does MRI lesion activity regress in secondary progressive multiple sclerosis?

Zhao Y, Petkau AJ, Traboulsee A, Riddehough A, Li DK.

Mult Scler. 2010 Apr;16(4):434-42. doi: 10.1177/1352458509359726. Epub 2010 Feb 18.

PMID:
20167592
19.

Intermediate highly active antiretroviral therapy adherence thresholds and empirical models for the development of drug resistance mutations.

Raffa JD, Tossonian HK, Grebely J, Petkau AJ, DeVlaming S, Conway B.

J Acquir Immune Defic Syndr. 2008 Mar 1;47(3):397-9. No abstract available.

PMID:
18398974
20.

Regression of new gadolinium enhancing lesion activity in relapsing-remitting multiple sclerosis.

Zhao Y, Traboulsee A, Petkau AJ, Li D.

Neurology. 2008 Mar 25;70(13 Pt 2):1092-7. Epub 2007 Nov 14.

PMID:
18003938
21.

The impact of ongoing illicit drug use on methadone adherence in illicit drug users receiving treatment for HIV in a directly observed therapy program.

Raffa JD, Grebely J, Tossonian H, Wong T, Viljoen M, Khara M, Mead A, McLean M, Duncan F, Petkau AJ, DeVlaming S, Conway B.

Drug Alcohol Depend. 2007 Jul 10;89(2-3):306-9. Epub 2007 Mar 23.

PMID:
17383117
22.

Application of hidden Markov models to multiple sclerosis lesion count data.

Altman RM, Petkau AJ.

Stat Med. 2005 Aug 15;24(15):2335-44.

PMID:
15909288
23.

Longitudinal analyses of the effects of neutralizing antibodies on interferon beta-1b in relapsing-remitting multiple sclerosis.

Petkau AJ, White RA, Ebers GC, Reder AT, Sibley WA, Lublin FD, Paty DW; IFNB Multiple Sclerosis Study Group.

Mult Scler. 2004 Apr;10(2):126-38.

PMID:
15124756
25.

Exposure misclassification and threshold concentrations in time series analyses of air pollution health effects.

Brauer M, Brumm J, Vedal S, Petkau AJ.

Risk Anal. 2002 Dec;22(6):1183-93.

PMID:
12530788
26.

Exposure of chronic obstructive pulmonary disease patients to particles: respiratory and cardiovascular health effects.

Brauer M, Ebelt ST, Fisher TV, Brumm J, Petkau AJ, Vedal S.

J Expo Anal Environ Epidemiol. 2001 Nov-Dec;11(6):490-500.

27.

Exposure of chronic obstructive pulmonary disease patients to particulate matter: relationships between personal and ambient air concentrations.

Ebelt ST, Petkau AJ, Vedal S, Fisher TV, Brauer M.

J Air Waste Manag Assoc. 2000 Jul;50(7):1081-94.

PMID:
10939202
28.

Natural killer cells in relapsing-remitting MS: effect of treatment with interferon beta-1B.

Kastrukoff LF, Morgan NG, Zecchini D, White R, Petkau AJ, Satoh J, Paty DW.

Neurology. 1999 Jan 15;52(2):351-9.

PMID:
9932956
29.

A role for natural killer cells in the immunopathogenesis of multiple sclerosis.

Kastrukoff LF, Morgan NG, Zecchini D, White R, Petkau AJ, Satoh J, Paty DW.

J Neuroimmunol. 1998 Jun 15;86(2):123-33.

PMID:
9663557
30.

Surveillance of clustering near point sources.

Le ND, Petkau AJ, Rosychuk R.

Stat Med. 1996 Apr 15-May 15;15(7-9):727-40.

PMID:
9132900
31.

Systemic lymphoblastoid interferon therapy in chronic progressive multiple sclerosis. I. Clinical and MRI evaluation.

Kastrukoff LF, Oger JJ, Hashimoto SA, Sacks SL, Li DK, Palmer MR, Koopmans RA, Petkau AJ, Berkowitz J, Paty DW.

Neurology. 1990 Mar;40(3 Pt 1):479-86.

PMID:
2179764
32.

Enrichment of progenitor cells from human bone marrow by flow cytometry.

Einspenner M, Sargent MD, Chelack WS, Petkau A.

Mol Cell Biochem. 1988 Dec;84(2):239-43.

PMID:
3231226
33.

Protection of bone marrow progenitor cells by superoxide dismutase.

Petkau A.

Mol Cell Biochem. 1988 Dec;84(2):133-40.

PMID:
3231219
34.

Free radicals in health and disease.

Singal PK, Petkau A, Gerrard JM, Hrushovetz S, Foerster J.

Mol Cell Biochem. 1988 Dec;84(2):121-2. No abstract available.

PMID:
3231218
35.

Objective criteria for in-vitro responses in human tumor colony-forming assays.

Koziol JA, Petkau AJ, Taetle R.

Med Decis Making. 1988 Oct-Dec;8(4):304-9.

PMID:
3185182
36.

Response of human bone marrow progenitor cells to X-rays in vitro.

Petkau A, Sargent MD, Chelack WS, Gerrard JM.

Int J Radiat Biol. 1988 Oct;54(4):593-600.

PMID:
2902157
37.

A calorimetric study of human CuZn superoxide dismutase.

Biliaderis CG, Weselake RJ, Petkau A, Friesen AD.

Biochem J. 1987 Dec 15;248(3):981-4.

38.

In vitro response of human bone marrow progenitor cells to superoxide radicals.

Petkau A, Chelack WS, Palamar E, Gerrard J.

Res Commun Chem Pathol Pharmacol. 1987 Jul;57(1):107-16.

PMID:
2823353
39.

Role of superoxide dismutase in modification of radiation injury.

Petkau A.

Br J Cancer Suppl. 1987 Jun;8:87-95. Review.

40.

Purification of human copper, zinc superoxide dismutase by copper chelate affinity chromatography.

Weselake RJ, Chesney SL, Petkau A, Friesen AD.

Anal Biochem. 1986 May 15;155(1):193-7.

PMID:
3717556
41.

Scientific basis for the clinical use of superoxide dismutase.

Petkau A.

Cancer Treat Rev. 1986 Mar;13(1):17-44. Review. No abstract available.

PMID:
3521852
43.

Simulated responses to intermittent lognormally distributed doses at variable dose rates.

Petkau A, Szekely JG, Perry KA.

Health Phys. 1984 Nov;47(5):745-52.

PMID:
6548988
44.

Effect of dose-rate on the frequency of X-linked lethal mutation in the nematode Panagrellus redivivus.

Ager D, Samoiloff MR, Petkau A.

Mutat Res. 1984 Jun-Jul;140(2-3):107-10.

PMID:
6749168
45.

Radioprotection by superoxide dismutase of macrophage progenitor cells from mouse bone marrow.

Petkau A, Chelack WS.

Biochem Biophys Res Commun. 1984 Mar 30;119(3):1089-95.

PMID:
6712667
46.

Wasted ventilation measured in vitro with eight anesthetic circuits with and without inline humidification.

Coté CJ, Petkau AJ, Ryan JF, Welch JP.

Anesthesiology. 1983 Nov;59(5):442-6.

PMID:
6579868
47.

Identifying superoxide-sensitive progenitor cells in mouse bone marrow.

Chelack WS, Petkau A.

Int J Radiat Biol Relat Stud Phys Chem Med. 1983 Nov;44(5):523-9.

PMID:
6315617
48.

Small-angle neutron scattering from native and irradiated superoxide dismutase in aqueous solution.

Martel P, Powell BM, Johnston RA, Petkau A.

Biochim Biophys Acta. 1983 Sep 14;747(1-2):78-85.

PMID:
6882780
49.

Simulated responses to lognormally distributed continuous low radiation doses.

Szekely JG, Perry KA, Petkau A.

Health Phys. 1983 Sep;45(3):699-711.

PMID:
6688409
50.

Effects of leukotrienes B4 and C4 on coronary circulation and myocardial contractility.

Michelassi F, Castorena G, Hill RD, Lowenstein E, Watkins WD, Petkau AJ, Zapol WM.

Surgery. 1983 Aug;94(2):267-75.

PMID:
6308844

Supplemental Content

Loading ...
Support Center